The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of REACH pts by Child-Pugh (CP) score.
 
Andrew X. Zhu
Consulting or Advisory Role - Eisai
 
Ari David Baron
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Lilly
 
Peter Malfertheiner
Speakers' Bureau - Aptalis; AstraZeneca; Takeda
 
Masatoshi Kudo
No Relationships to Disclose
 
Seiji Kawazoe
No Relationships to Disclose
 
Denis Pezet
No Relationships to Disclose
 
Florian Weissinger
Honoraria - Lilly; Roche Pharma AG
Consulting or Advisory Role - Lilly; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Lilly
 
Giovanni Brandi
No Relationships to Disclose
 
Carlo Barone
No Relationships to Disclose
 
Takuji Okusaka
Honoraria - Bayer Yakuhin; Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Chugai Pharma; Dainippon Sumitomo Pharma; Lilly; NanoCarrier; Nippon Boehringer Ingelheim; Nobelpharma; Novartis; OncoTherapy Science; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Research Funding - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; Kowa; Kyowa Hakko Kirin; Lilly; Merck Serono; Nippon Boehringer Ingelheim; Novartis; OncoTherapy Science; Ono Pharmaceutical; Otsuka; Pfizer; Sceti Medical Labo; Shizuoka; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Yoshiyuki Wada
No Relationships to Disclose
 
Joon Oh Park
Research Funding - GlaxoSmithKline; Sanofi
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Jae Yong Cho
No Relationships to Disclose
 
Hyun Cheol Chung
Consulting or Advisory Role - Celltrion; Lilly
 
Chung-Pin Li
No Relationships to Disclose
 
Chia-Jui Yen
No Relationships to Disclose
 
Kuan-Der Lee
No Relationships to Disclose
 
Ling Yang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Patents, Royalties, Other Intellectual Property - Lilly
 
Ian Chau
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Gilead Sciences; Merck Serono; Sanofi
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche Pharma AG (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Sanofi